²é¿´: 1384  |  »Ø¸´: 3
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

zhangchong2303

½ð³æ (СÓÐÃûÆø)

[ÇóÖú] °¢Âå·ò¶¨£¨alovudine£©ÐÂÒ©ÁÙ´²¼¸ÆÚ£¿

ÇóÖú¸÷λ´óÏÀ£¬ÎÒÏë²éѯһϰ¢Âå·ò¶¨£¨alovudine£©ÐÂÒ©ÁÙ´²µ½¼¸ÆÚ¡£Ò»ÏÂÎÒÊÇÃÀ¹úµÄclinicaltrialÉÏÃæ²éµ½µÄÐÅÏ¢£¬¿´²»¶®ÊǼ¸ÆÚÔõôÅжϡ£
Found 14 studies with search of: Alovudine
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.   Display Options Rank Status Study
1 Completed  An Open-Label, Crossover Study to Assess the Effect of Food on the Oral Bioavailability and Pharmacokinetic Profile of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects Condition:  HIV Infections
Intervention:  Drug: Alovudine

2 Completed  An Ascending, Single Oral Dose Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects Condition:  HIV Infections
Intervention:  Drug: Alovudine

3 Completed  A Multi-Center, Open-Label, Ascending, Multiple Oral Dose, Safety, Tolerance and Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Patients With Acquired Immune Deficiency Syndrome (AIDS) or AIDS-Related Complex (ARC) Condition:  HIV Infections
Intervention:  Drug: Alovudine

4 Recruiting  Monitor Response to Treatment in Neuroblastoma Using 3'-Deoxy-3'-Fluorothymidine- Positron Emission Tomography (FLT-PET) Condition:  Neuroblastoma
Intervention:  Device: FLT-PET

5 Recruiting  Assessment of 18FLT PET-CT for Volume Definition of High-grade Gliomas (GLIO-TEP) Conditions:  High-grade Glioma;   Astrocytoma;   Glioblastoma
Intervention:  Radiation: 18F Fluorothymidine PET CT

6 Recruiting  Study of BMS-754807 Combined With Letrozole or BMS-754807 Alone in Patients With Hormone Receptor-Positive Breast Cancer and Resistance to Non-Steroidal Aromatase Inhibitors Condition:  Breast Cancer
Interventions:  Drug: BMS-754807;   Drug: letrozole

7 Recruiting  A Study to Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma Conditions:  Cancer;   Solid Tumor;   Lymphoma
Intervention:  Biological: 18F-FLT

8 Recruiting  Image-Guided Stereotactic Biopsy of High Grade Gliomas Conditions:  Brain Cancer;   Glioma
Intervention:  Procedure: 18F-FLT PET Scan

9 Completed  18F-FLT-PET in Breast Cancer (MK-0000-139 AM1) Condition:  Breast Cancer
Intervention:  Procedure: 18F-FLT-Positron Emission Tomography (PET)/Computed Tomography (CT) Imaging

10 Recruiting  Pilot Study of 18F-FLT PET Conditions:  CNS Brain Metastasis;   Head and Neck Cancer;   Lung Cancer;   Prostate Cancer;   Esophageal Cancer
Intervention:  Procedure: Imaging with 18F-FLT PET

11 Terminated  A Pilot Study of 18F-FLT in Pediatric Patients With Central Nervous System (CNS) Tumors Condition:  Tumors of the Central Nervous System
Intervention:  Other: [18F]-Fluorothymidine

12 Recruiting  An Imaging Pilot Study of 18F-fluoro-3'-Deoxy-3'-L-fluorothymidine (18F-FLT) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Who Will be Treated With Gemcitabine Condition:  Pancreatic Cancer
Intervention:  Procedure: Positron-Emission Tomography (PET) 18F-FLT

13 Recruiting  Validation of 18F-MISO-PET and 18F-FLT-PET Condition:  Head and Neck Neoplasms
Intervention:  Procedure: 18F-FLT and 18F-MISO-PET

14 Recruiting  Clinical Application of 18F-3'-Fluoro-3'-Deoxy-L-thymidine (18F-FLT) Positron Emission Tomography (PET) in Lung Tumors Condition:  Lung Cancer
Intervention:   
Çó½âÊÍ£¬·Ç³£¸Ðл
»Ø¸´´ËÂ¥

» ÊÕ¼±¾ÌûµÄÌÔÌûר¼­ÍƼö

ÐÂÒ©·¢ÏÖ

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

iamzane

ÖÁ×ðľ³æ (ÖøÃûдÊÖ)

Â¥Ö÷£¬ÄãÒªµã»÷½øÈ¥¿´µÄ
4Â¥2012-02-02 13:53:25
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 4 ¸ö»Ø´ð

nkbeholder

ľ³æ (ÕýʽдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
lk590(½ð±Ò+1): лл²ÎÓë 2012-02-02 11:31:54
zhangchong2303(½ð±Ò+10): ¡ï¡ï¡ïºÜÓаïÖú лл£¬´ÓÕâÉÏÃæ¿´Ó¦¸ÃÊÇÁÙ´²2ÆÚ£¬ÊÇÂ𣿠2012-02-02 13:47:37
dialogÉϵÄÐÅÏ¢£¬¸üе½2007Äê
Originator Company: Medivir AB (Sweden)
Parent Company: Medivir AB
Licensee: Beijing Mefuvir Medicinal Technology

Highest Phase: Discontinued II

Development Status:
Discontinued II, France, HIV infections treatment
Discontinued II, Sweden, HIV infections treatment
Discontinued II, USA, HIV infections treatment
2Â¥2012-02-02 11:28:31
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

nkbeholder

ľ³æ (ÕýʽдÊÖ)

ËûÕâ¶ù¶¼DiscontinuedÁË¡£ÇÒ2007ÄêÖ®ºó¾ÍûÏûÏ¢ÁË¡£
²»ÖªµÀclinicaltrialÉÏÃæÕÐﲡÈËÊÇʲôʱºò£¿
3Â¥2012-02-02 13:49:56
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[»ù½ðÉêÇë] ÌåÖÆÄÚ³¤±²ËµÌåÖÆÄÚ¾ø´ó²¿·ÖÒ»±²×ÓÔڵײ㣬ÈçͬÄãÃÇÒ»Ñù´ó²¿·ÖÆÕͨ½ÌʦæÇÒÊÕÈëµÍ +10 ˲ϢÓîÖæ 2026-02-20 13/650 2026-02-23 11:23 by holypower
[˶²©¼ÒÔ°] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +3 8rmuugja8q 2026-02-22 7/350 2026-02-23 09:44 by w4l55oybr1
[¿¼ÑÐ] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +3 khieu8v8m0 2026-02-22 8/400 2026-02-23 09:35 by w4l55oybr1
[ÂÛÎÄͶ¸å] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +4 khieu8v8m0 2026-02-22 8/400 2026-02-23 09:29 by w4l55oybr1
[¿¼ÑÐ] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +5 usprnugpzw 2026-02-21 11/550 2026-02-23 09:24 by w4l55oybr1
[½Ìʦ֮¼Ò] ΪʲôÖйú´óѧ¹¤¿Æ½ÌÊÚÃÇË®ÁËÄÇô¶àËùνµÄ¶¥»á¶¥¿¯£¬µ«»¹ÊÇ×ö²»³öÓîÊ÷»úÆ÷ÈË£¿ +5 »¶ÀÖËÌÒ¶Ýè 2026-02-21 8/400 2026-02-23 09:19 by »¶ÀÖËÌÒ¶Ýè
[ÂÛÎÄͶ¸å] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +3 w89i99eaeh 2026-02-22 5/250 2026-02-23 08:04 by w4l55oybr1
[²©ºóÖ®¼Ò] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +4 khieu8v8m0 2026-02-22 6/300 2026-02-23 07:59 by w4l55oybr1
[²©ºóÖ®¼Ò] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +6 3dfhjxgsh7 2026-02-22 9/450 2026-02-23 07:49 by w4l55oybr1
[¿¼²©] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +4 khieu8v8m0 2026-02-22 4/200 2026-02-23 06:46 by jsjzfl
[¹«Åɳö¹ú] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +3 khieu8v8m0 2026-02-22 5/250 2026-02-23 06:29 by w4l55oybr1
[¿¼²©] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +5 3dfhjxgsh7 2026-02-22 6/300 2026-02-23 02:04 by 5jlh3qtdvx
[½Ìʦ֮¼Ò] °æÃæ·Ñ¸Ã½»Âð +7 Æ»¹ûÔÚÄÄÀï 2026-02-22 8/400 2026-02-22 22:37 by otani
[»ù½ðÉêÇë] ÃæÉÏ¿ÉÒÔ³¬¹ý30Ò³°É£¿ +4 °¢À­¹±aragon 2026-02-22 4/200 2026-02-22 21:22 by ɽÎ÷Ðü¿ÕË¿ÕÐüÎ
[ÂÛÎÄͶ¸å] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +4 usprnugpzw 2026-02-21 6/300 2026-02-22 19:48 by w89i99eaeh
[¿¼ÑÐ] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +3 3dfhjxgsh7 2026-02-22 4/200 2026-02-22 16:52 by khieu8v8m0
[ÕÒ¹¤×÷] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +3 usprnugpzw 2026-02-22 3/150 2026-02-22 16:37 by khieu8v8m0
[¹«Åɳö¹ú] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +3 usprnugpzw 2026-02-21 4/200 2026-02-22 16:27 by khieu8v8m0
[»ù½ðÉêÇë] ¡°ÈËÎÄÉç¿Æ¶øÂÛ£¬Ðí¶àѧÊõÑо¿»¹Ã»ÓдﵽÃñ¹úʱÆÚµÄˮƽ¡± +4 ËÕ¶«ÆÂ¶þÊÀ 2026-02-18 5/250 2026-02-22 16:07 by liangep1573
[»ù½ðÉêÇë] ½ñÄê´ºÍíÓм¸¸ö½ÚÄ¿ºÜ²»´í£¬µãÔÞ£¡ +11 ˲ϢÓîÖæ 2026-02-16 12/600 2026-02-21 21:14 by lq493392203
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û